All Disease Treatment & Prevention articles – Page 4
-
NewsFirst 24 hours after viral infection are critical
New research suggests that the first 24 hours after viral infection is critical in determining infection severity.
-
NewsNew discovery could help scientists fight deadly fungal infections
Researchers have discovered that the bacterial antibiotic ‘gladiolin’ can disarm Candida albicans, one of the leading causes of life-threatening fungal infections, opening new avenues for developing life-saving treatments.
-
NewsToo much RNA can starve cells of energy
Researchers uncover a link between excess RNA and mitochondrial damage — revealing new insights into viral infections, aging and RNA-based therapeutics.
-
NewsNext-gen mRNA therapeutics get a new delivery vehicle
Researchers have developed a novel way of delivering circular RNA into cells, paving way for long-lasting mRNA-based therapeutics including cancer vaccines and obesity treatments.
-
NewsModeling social inequality in epidemics
New study introduces a metric into disease-transmission models which quantifies the degree to which social determinants of health — like neighborhood, access to healthcare, or economic status — cause outbreaks.
-
NewsClimate change predicted to drive changes in diarrheal disease prevalence in several countries in Africa
Researchers have identified key social and environmental factors that influence how climate change affects childhood diarrheal diseases in sub-Saharan Africa.
-
NewsPreventing the accumulation of mRNA-loaded lipid nanoparticles in the liver
New research has developed a novel coating agent that prevents lipid nanoparticles from accumulating in the liver—a major practical challenge when using lipid nanoparticles in vaccines and immunotherapies.
-
NewsPre-existing antibodies linked to different immune responses after influenza vaccination
New study highlights how previous exposure to influenza viruses and vaccines can leave behind pre-existing antibodies, which may influence how the immune system responds to later vaccination.
-
NewsDevelopment of dual-action compounds to fight cancer and infections
Researchers have developed new hybrid compounds that simultaneously reduce the viability of aggressive cancer cells and inhibit the growth of certain bacteria and fungi.
-
NewsGut-pancreas immune crosstalk may offer new therapeutic strategies for pancreatic cancer
A new study reports that immune responses produced in lymph nodes shared by the liver, pancreas and intestine shape T-cell tolerance. This cross-organ immune rewiring increases T-cell infiltration into pancreatic tumors, pointing to potential new approaches for hard-to-treat pancreatic cancers.
-
NewsDoctoral student aims to detect insect-borne viruses sooner
A biomedical engineering doctoral student at the University of Nebraska is developing generative foundation models to forecast the emergence of arboviruses before they spill over into humans.
-
News‘Known’ TB gene springs to action under stress, with an unexpected biological role
New research has discovered that one of TB’s supposedly “known” genes has a completely unexpected biological role, with far-reaching implications.
-
NewsPreventive TB treatment for individuals with HIV shown to be effective in real-world settings
A new study has evaluated the real-world impact of TB preventive treatment in six countries with high TB and HIV rates and highlights the importance of preventive treatment in reducing deaths caused by a curable disease.
-
News35-year study reshapes our understanding of Lyme disease ecology
Researchers reveal surprising findings from one of the world’s longest-running ecological monitoring programs tracking ticks and their hosts.
-
NewsEngineered macrophages gain enhanced bacteria-targeting ability
A novel membrane interface engineering strategy enables immune cells to specifically recognize, capture and eliminate pathogenic bacteria without genetic modification.
-
NewsResearchers identify rapidly spreading genetic variants that make parasites resistant to malaria treatment
New genetics study helps explain declining malaria drug susceptibility and highlights the urgent need to track mutations and improve current therapies.
-
NewsAlbumin is prevented from crossing the placenta – opening opportunities for design of long-acting biologic medicines
Researchers have uncovered that the placenta distinguishes between antibodies and albumin, a finding that may reshape the future design of biologic medicines with reduced fetal exposure.
-
NewsCell ‘invisibility cloaks’ could offer side-effect-free diabetes treatment
New research suggests manufacturing cells an “invisibility cloak” out of a jelly-like material known as hydrogel, may offer an easier, less damaging treatment pathway for people with diabetes undergoing cell therapy.
-
NewsUC San Diego receives $12.3 million grant to study the intersection of HIV and methamphetamine use
A newly funded programme aims to use a multidisciplinary approach focused on improving the clinical care and brain health of people with HIV who also have an active methamphetamine use disorder.
-
NewsStable RNA elements open new possibilities for mRNA therapeutics
New research has discovered compact viral RNA elements that can make mRNA more stable, and could provide a simple way to develop longer-lasting and more efficient mRNA technologies for vaccines and other RNA-based therapeutics.